481 results on '"Fromenty, Bernard"'
Search Results
2. Weight of evidence evaluation of the metabolism disrupting effects of triphenyl phosphate using an expert knowledge elicitation approach
3. Low concentrations of ethylene bisdithiocarbamate pesticides maneb and mancozeb impair manganese and zinc homeostasis to induce oxidative stress and caspase-dependent apoptosis in human hepatocytes
4. Mitochondrial remodeling and energy metabolism adaptations in colonic crypts during spontaneous epithelial repair after colitis induction in mice
5. Contributors
6. Discovery of amiodarone mitochondrial toxicity in liver and beyond
7. NAFLD et dysfonction mitochondriale
8. The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds.
9. Mitochondrial alterations in fatty liver diseases
10. Drug-induced impairment of mitochondrial fatty acid oxidation and steatosis: assessment of causal relationship with 45 pharmaceuticals
11. Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure
12. Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians
13. Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity
14. Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis
15. Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids
16. Drug-Induced Mitochondrial Toxicity
17. Mechanisms involved in the death of steatotic WIF-B9 hepatocytes co-exposed to benzo[a]pyrene and ethanol: a possible key role for xenobiotic metabolism and nitric oxide
18. Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug‐induced liver injury.
19. Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug‐induced liver injury
20. New genome scale network modeling and mining workflow for detecting metabolic changes induced by exposure to chemicals
21. Contributors
22. Mitochondrial Dysfunction Induced by Xenobiotics: Involvement in Steatosis and Steatohepatitis
23. Drug-induced liver injury in obesity and nonalcoholic fatty liver disease
24. Supplementary Data from Retrodifferentiation of Human Tumor Hepatocytes to Stem Cells Leads to Metabolic Reprogramming and Chemoresistance
25. Data from Retrodifferentiation of Human Tumor Hepatocytes to Stem Cells Leads to Metabolic Reprogramming and Chemoresistance
26. Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
27. Mitochondrial Dysfunction in Drug-Induced Liver Injury
28. In Vitro Assessment of Mitochondrial Toxicity to Predict Drug-Induced Liver Injury
29. Mitochondrial Involvement in Drug-Induced Liver Injury
30. Aggravation des hépatopathies liées à l’obésité par les xénobiotiques
31. Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure.
32. The effect of water suppression on the hepatic lipid quantification, as assessed by the LCModel, in a preclinical and clinical scenario
33. Drug-Induced Microvesicular Steatosis and Steatohepatitis
34. Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies
35. Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease
36. Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver
37. Beneficial effects of citrulline enteral administration on sepsis-induced T cell mitochondrial dysfunction
38. Acetaminophen (APAP, Paracetamol) Interferes With the First Trimester Human Fetal Ovary Development in an Ex Vivo Model
39. Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease
40. Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver
41. Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen
42. Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease
43. Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients
44. Advanced preclinical models for evaluation of drug-induced liver injury – consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]
45. Advanced preclinical models for evaluation of drug-induced liver injury – consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]
46. Mitochondrial dysfunction in nonalcoholic steatohepatitis (NASH): are there drugs able to improve it?
47. Cocktail de pesticides et stéatose hépatique
48. Drug-Induced Inhibition of Mitochondrial Fatty Acid Oxidation and Steatosis
49. Regulation of hepatic mitochondrial metabolism in response to a high fat diet: a longitudinal study in rats
50. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.